Assessment of Heart Rate Measurement Accuracy for the PreemptiveAI SDK in Adults

N/AActive Not RecruitingNCT06696339

PreemptiveAI, Inc100 enrolled

Overview

The goal of this clinical trial is to assess the accuracy of the PreemptiveAI SDK to measure heart rate for adults as compared to an FDA-approved ground truth device. Participants will: * Complete a demographics and health history survey * Apply and wear ground truth equipment such as a pulse oximeter and ECG * Measure their heart rate 8 times with 4 different smartphones using the PreemptiveAI SDK

Study Type

OBSERVATIONAL

Enrollment

100

Conditions

Heart Rate in the General Public

Interventions

PreemptiveAI SDKDEVICE

Use the PreemptiveIAI SDK to measure heart rate.

Eligibility

Sex: ALLMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Adults with both normal and abnormal heart rates Exclusion Criteria: * Under 18 years of age * Unable to speak and read English * Deemed not suitable to participate by Investigator due to cognitive impairment, acute illness, or serious physical or mental health condition * Essential tremor in left or right hand * Raynaud's disease * Severe calluses on left or right index finger * Unable to produce a heart rate measurement due to low signal quality during the training phase (i.e. low perfusion, unable to hold hand steady, etc)

Locations (1)

Paul Allen Institute for Artificial Intelligence

Seattle, Washington, United States

Outcomes

Primary Outcomes

Heart Rate Error

Root mean square error of heart rate compared to ground truth device

Time frame: At single site visit, measured across 8 repetitions within a 1-hour period

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.